MedPath

Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD

Not Applicable
Not yet recruiting
Conditions
COPD
Registration Number
NCT07045948
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

This study aims to evaluate how airway inflammation, lung function, and symptoms change over time in people with chronic obstructive pulmonary disease (COPD). Airway inflammation will be assessed using a simple breath test (FeNO) and a small blood sample to measure eosinophils, a type of white blood cell. Participants will be followed for one year, with three study visits (at the start, 6 months, and 12 months). The goal is to understand how these markers evolve and whether they differ between people who experience a worsening of symptoms (called exacerbations) and those who remain stable. All tests except for a small extra blood draw are part of routine COPD care. Participation does not affect standard treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults aged ≥ 40 years
  • Diagnosed with COPD according to GOLD criteria
  • Attending routine follow-up visits every 6 months
  • Ability to provide informed consent
Exclusion Criteria
  • Recent respiratory tract infection or exacerbation (either moderate or se-vere) (<4 weeks before inclusion)
  • Dominant asthmatic phenotype (ACO with asthma predominance)
  • Severe comorbidities interfering with participation or follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To evaluate the longitudinal stability of FeNO levels in COPD patients over a 12-month period with biannual measurements.from enrollment to the end of the study period (1 year)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath